Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 04. April 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9340  Previews Next
   
   Articles 1 - 20 / 186793  
   
Improving the diagnosis of renal tumours of young people through integrated molecular analysis.
J Cancer Res Clin Oncol
Leiter SM, Guobadia AO, Fleming B, Ajithkumar TV, Armitage JN, Burke GAA, Burns CM, Coleman N, Hatcher H, Horan G, Long AM, McDonald S, Mitchell TJ, Nicholson JC, Roberts T, Stewart GD, Tadross JA, Tarpey PS, Trayers C, Trotman J, Watkins JA, Warren AY, Vujanic GM, Armstrong R, Behjati S, Hook CE, Murray MJ.
PMID: 41933220 [PubMed - indexed for MEDLINE]


Assessing inter-observer variability in prostate and GTV segmentation on mpMRI: A comparison between radiation oncologists and AI-based method.
J Appl Clin Med Phys
Dionne P, Martin AG, Ouellet É, Roy JC, Sidibé I, Froment MA, Vigneault É, Foster W, Bachand F, Archambault L, Poulin É.
PMID: 41932854 [PubMed - indexed for MEDLINE]


Unmasking prostate cancer risk factors leveraging organoid technology.
Gene
Cantarelli M, Marmocchi E, Lunardi A, Begaj R.
PMID: 41932411 [PubMed - as supplied by publisher]


Motivations and experiences of high-risk men in risk-adapted prostate cancer early detection: A qualitative study.
Patient Educ Couns
Klett MK, Balkan I, Lakes J, Albers P, Hiltrop K, Rother J, Boschheidgen M, Antoch G, Redler S, Wieczorek D, Fehm T, Jaeger BAS, Dinger U, Karger A.
PMID: 41932171 [PubMed - as supplied by publisher]


Utility of FRET substrates in bladder cancer diagnosis.
Bioorg Chem
Gruba N, Stachurski L, Lesner A.
PMID: 41932036 [PubMed - as supplied by publisher]


A survivorship-oriented enhanced care model for patients undergoing radical prostatectomy.
PLoS One
Yuan X, Chen Y, Lu H, Zheng P, Zhang Y, Chen M, Sheng X.
PMID: 41931550 [PubMed - indexed for MEDLINE]


A radiomics-based interpretable model to distinguish Xp11.2/TFE3 translocation renal cell carcinoma and common types of renal cell carcinoma on CT images.
Cancer Treat Res Commun
Liu Y, Shen Q, Wang K, Zhang Y, Liu J, Qiu J, Wang X.
PMID: 41930555 [PubMed - as supplied by publisher]


Predictors of acute lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a real-world prospective multi-centric study.
ESMO Real World Data Digit Oncol
Vavassori V, Pavarini M, Alborghetti L, Aimonetto S, Maggio A, Landoni V, Ferrari P, Bianculli A, Petrucci E, Cicchetti A, Farina B, Ubeira-Gabellini MG, Salmoiraghi P, Moretti E, Avuzzi B, Giandini T, Munoz F, Magli A, Noris Chiorda B, Sanguineti G, Waskiewicz JM, Rago L, Cante D, Girelli G, Villa E, Di Muzio NG, Rancati T, Fiorino C, Cozzarini C.
PMID: 41930300 [PubMed]


Multi-omics integration identifies PGAP3 as a tumor-intrinsic factor associated with CD8(+) T-cell exclusion in prostate cancer.
Front Mol Biosci
Liu W, Li G, Lei Y, Liu H, Wang B, Deng W, Hong Y, Long X.
PMID: 41930249 [PubMed]


Adolescent Renal Tumours: Diagnostic and Therapeutic Challenges in a Transitional Age Group-A Multidisciplinary Case Report Series from a Single Center.
Oncol Res
Ruggiero A, Fuccillo F, Paola VD, Romano A, Maurizi P, Talloa D, Foschi N, Russo P, Racioppi M, Mastrangelo S, Attinà G.
PMID: 41930178 [PubMed - indexed for MEDLINE]


Serum Biomarkers in Bladder Cancer: NMR Metabolomics for Identification and Monitoring during Platinum-Based Therapy.
Oncol Res
Giorgione R, Grasso D, Gambale E, Scolari F, Rossi V, Maida FD, Mela MM, Marzocchi B, Doni L, Pasqui A, Minervini A, Caliman E, Serni S, Bernini A, Pillozzi S, Antonuzzo L.
PMID: 41930155 [PubMed - indexed for MEDLINE]


Absence of bladder cancer cells in surgical smoke from robot-assisted radical cystectomy: a prospective study.
Front Urol
Shibamori K, Hashimoto K, Okabe K, Maehana T, Shindo T, Kyoda Y, Kobayashi K, Tanaka T, Takahashi S, Masumori N.
PMID: 41929665 [PubMed]


Cancer Genomic Medicine for Urological Malignancies in Japan.
Int J Urol
Sato Y, Fujii Y, Kume H.
PMID: 41928709 [PubMed - indexed for MEDLINE]


The Association Between Metabolic Syndrome and Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.
Am J Mens Health
Gao W, Guo Y, Yu X, Zhang T, Gong H, Zhang Y.
PMID: 41928554 [PubMed - indexed for MEDLINE]


Learning Curve and Surgeon Experience in En Bloc Transurethral Resection of Bladder Tumour: A Retrospective Cohort Study.
ANZ J Surg
Creffier CWG, Chemasle C.
PMID: 41928487 [PubMed - as supplied by publisher]


Experiential Aspects in Patients With Permanent Urostomy Following Bladder Cancer Surgery: Meta-Synthesis of Qualitative Studies.
Nurs Open
Zhou L, Chen Y, Yuan X, Guo F, Feng H, Li Y, Li S, Fang Z, Zhao J.
PMID: 41928070 [PubMed - indexed for MEDLINE]


Comparison of Perioperative and Oncologic Outcomes Between Robotic and Open Retroperitoneal Lymph Node Dissection in Testicular Cancer: A Systematic Review and Meta-analysis.
Ann Surg Oncol
Zhao P, Tan X, Xie Y, Deng R, Peng F.
PMID: 41927958 [PubMed - as supplied by publisher]


Unveiling the Clinical Potential of Prostate Cancer Three-dimensional Models: A Systematic Review.
Eur Urol Oncol
Peyrottes A, de Brek N, Vieira Aleixo AS, Baboudjian M, Anract J, Roupret M, Timsit MO, Méjean A, Guidotti JE, Goffin V, Dariane C.
PMID: 41927412 [PubMed - as supplied by publisher]


Dosimetry Analysis of (177)Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial.
J Nucl Med
Ells Z, Meyer C, Kimura K, Wilhalme H, Cao M, Ludwig VB, Unterrainer LM, Sennung D, Nabong R, Felix C, Valle LF, Daley A, Czernin J, Dahlbom M, Kishan AU, Calais J.
PMID: 41927282 [PubMed - as supplied by publisher]


[(177)Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study.
Lancet Oncol
Sandhu S, Joshua AM, Emmett L, Bressel M, Anton A, Spain L, Horvath LG, Pasam A, Tolmeijer SH, Akhurst TJ, Alipour R, Banks P, Buteau JP, Cassidy E, Crumbaker M, Dhiantravan N, Xu W, Chan J, Hitchen N, Scalzo M, Ravi Kumar AS, Kong G, Wallace R, Williams N, Williams S, Haynes NM, Neeson P, Wyatt AW, Hicks RJ, Hofman MS.
PMID: 41926961 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 186793    Page 1 of 9340  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1